Wingstop Shares Slide 12 After Quarterly Profit Misses Analyst Expectations Signos Raises 20M in Funding Expands Dexcom Partnership to Capitalize on GLP1 Weight Loss Trend Trump Advises Caution in Iran Negotiations as Strait of Hormuz Reopening Considered SK Hynix and Micron Join 1 Trillion Club as AI Resurgence Drives Semiconductor Surge Department of Energy Highlights Progress in PlugIn Electric Vehicle and Battery Technology Accenture and HUMAIN Join Forces to Boost AI Adoption in Saudi Arabia BOTJ Q1 2025 Earnings Positive EPS Performance Amidst Limited Guidance Visibility POWI Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Uncertainty HSIC Q1 2026 Earnings EPS Beat of 631 Surprises Analysts EPM Q1 2026 Earnings Deep EPS Miss Punishes Stock as Revenue Details Remain Unreported CETY Q4 2024 Earnings Net Loss Widens as Stock Declines Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss as Pipeline Progress Takes Center Stage RWAYI Holds Steady Near Support Runway Growth Finance Notes Show Resilience Amid Rate Uncertainty Blackstone Mortgage Trust BXMT Slides 116 as Rate Sensitivity Weighs Axsome Therapeutics AXSM Edges Lower Maintains Posture Above NearTerm Support Cisco Systems CSCO Edges Higher Amid Market Resilience Key Levels in Focus G WilliFood International WILC Gains 155 as Shares Test Key Resistance Zone Federal Realty Investment Trust Stock Tracks Market Closely Outperforms in 2026 GPN Q1 2026 Earnings EPS Surpasses Estimates with 366 Surprise The GrowHub Limited TGHL Gains 356 Approaching Key Resistance Level ELVA Q1 2026 Earnings EPS Surprise of 307 Drives Optimism Buda Juice Inc BUDA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency CAAP Q1 2026 Earnings EPS Misses Estimates Stock Gains on Operational Resilience GWRE Q1 2026 Earnings Strong EPS Beat Drives Stock Higher APPS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction ZBIO Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Pipeline CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue